Share
Manila: The Asian Development Bank (ADB) has joined with leading public health experts, vaccine regulators, and policy makers to form an advisory group to provide its developing member countries (DMCs) with expert technical and scientific advice on the quality, safety, and effectiveness of vaccines for the coronavirus disease (COVID-19) pandemic.
The Regional Vaccine Advisory Group held its first meeting today and will help ADB and its DMCs better understand the regulatory oversight, risk management strategies, and pharmacovigilance needed to safely introduce and monitor vaccine rollouts.
“For most of the world, including Asia and the Pacific, the pandemic continues to disrupt lives and economies, and, in some countries, it is intensifying,” said ADB President Masatsugu Asakawa. “ADB’s Regional Vaccine Advisory Group will help to safely introduce COVID-19 vaccines across Asia and the Pacific, and allow people to resume their lives, revive their economies, and in doi
ADB Establishes High-Level Advisory Group for COVID-19 Vaccines adb.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adb.org Daily Mail and Mail on Sunday newspapers.
Amidst a shortage of vaccines in the second wave of COVID-19, the government is now expecting a speedy launch of Sputnik Light, Russia’s single-dose vaccine, in India, reported PTI.
Drugs Controller General of India (DCGI) informed other participants that the application for regulatory approval of Sputnik Light is expected to be filed in the next 2-3 weeks.
The two-dose Sputnik V had received the Indian drug regulator's permission for restricted emergency use with certain conditions on April 12. Dr Reddy's Laboratories is importing the vaccine for use in India.